Overview

Entyvio (Vedolizumab) Long Term Safety Study

Status:
Completed

Trial end date:
2021-08-03

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the long-term safety of vedolizumab versus other biologic agents in participants with Ulcerative Colitis (UC) or Crohn's Disease (CD).

Details

Lead Sponsor:

Takeda

Treatments:

Vedolizumab